Literature DB >> 20869226

Costs of COPD exacerbations in the emergency department and inpatient setting.

Anand A Dalal1, Manan Shah, Anna O D'Souza, Pallavi Rane.   

Abstract

BACKGROUND: Exacerbations of COPD contribute to lung function decline and reduced quality of life. Treatment of exacerbations in the hospital setting is costly, but information concerning the component cost drivers of this care is scarce. Our objective was to describe and characterize costs of COPD care in the hospital setting.
METHODS: Administrative data from 602 hospitals were used to calculate 2008 costs for COPD-related emergency department (ED) visits, simple inpatient admissions and complex admissions (categorized as intubation/no intensive care, intensive care/no intubation, or intensive care/intubation) among COPD patients' age ≥ 40 years. Inpatient mortality, length of stay (LOS), and readmission rates in 2005-2008 were also calculated.
RESULTS: Mean 2008 costs were $647 (SD $445) for ED visits (n = 24,617), $7242 ($7987) for simple admissions (n = 42,734), and $20,757 ($41,370) for complex admissions (n = 4142). Intensive care/intubation admissions incurred the highest costs ($44,909 [SD, $80,351]; n = 838). Complex admissions accounted for 5.8% of hospital-based COPD care in 2008, but 20.9% of costs. Mean LOS ranged from 4.5 days (SD 3.3) for simple admissions to 16.0 days (16.7) for intensive care/intubation admissions. Death occurred in 0.9% of simple admissions, 10.3% of all complex admissions, and 26.5-39.1% of admissions involving intubation. Readmission rates within 30-60 days for ED visits, simple admissions and complex admissions were 17.8%, 15.3% and 15.7%, respectively. From 2005 to 2008, trends in LOS were relatively flat; inflation-adjusted costs increased 4.0-5.9%.
CONCLUSIONS: Costs of hospital-based care for COPD are substantial. Admissions involving intubation or intensive care are associated with the highest costs, LOS, and mortality.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20869226     DOI: 10.1016/j.rmed.2010.09.003

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  33 in total

Review 1.  Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.

Authors:  Kunal Srivastava; Deepika Thakur; Sheetal Sharma; Yogesh Suresh Punekar
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

Review 2.  Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.

Authors:  Sara M May; James T C Li
Journal:  Allergy Asthma Proc       Date:  2015 Jan-Feb       Impact factor: 2.587

3.  Dual Medicare and Veteran Health Administration use and ambulatory care sensitive hospitalizations.

Authors:  Mayank Ajmera; Tricia Lee Wilkins; Usha Sambamoorthi
Journal:  J Gen Intern Med       Date:  2011-11       Impact factor: 5.128

Review 4.  Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.

Authors:  Christopher M Blanchette; Nicholas J Gross; Pablo Altman
Journal:  Am Health Drug Benefits       Date:  2014-04

5.  Comparison of Methods To Identify Advance Care Planning in Patients with Severe Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Amanda Renee Stephens; Renda Soylemez Wiener; Michael H Ieong
Journal:  J Palliat Med       Date:  2017-08-29       Impact factor: 2.947

6.  Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2016-02

7.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

8.  MODELING CHRONIC DISEASE PATIENT FLOWS DIVERTED FROM EMERGENCY DEPARTMENTS TO PATIENT-CENTERED MEDICAL HOMES.

Authors:  Rafael Diaz; Joshua Behr; Sameer Kumar; Bruce Britton
Journal:  IIE Trans Healthc Syst Eng       Date:  2015

9.  Comprehensive and Collaborative Pharmacist Transitions of Care Service for Underserved Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jennifer Kim; Amy Lin; Randy Absher; Tanya Makhlouf; Casey Wells
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

10.  Impact of Proactive Integrated Care on Chronic Obstructive Pulmonary Disease.

Authors:  Patricia B Koff; Sung-Joon Min; Tammie J Freitag; Debora L P Diaz; Shannon S James; Norbert F Voelkel; Derek J Linderman; Fernando Diaz Del Valle; Jonathan K Zakrajsek; Richard K Albert; Todd M Bull; Arne Beck; Thomas J Stelzner; Debra P Ritzwoller; Christine M Kveton; Stephanie Carwin; Moumita Ghosh; Robert L Keith; John M Westfall; R William Vandivier
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.